ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway-Reference-Cited by-同舟云学术

ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway

Published:2024-09-12 Issue:1 Volume:22 Page:
ISSN:1477-3155
Container-title:Journal of Nanobiotechnology
language:en
Short-container-title:J Nanobiotechnol

Author:

Wu Yixuan,Bao Hongyi,Wu Jinran,Chen Bairong,Xu Jing,Jin Kangfeng,Chen Lin,Zhu Guang,Wang Feng

Funder

National Outstanding Youth Science Fund Project of National Natural Science Foundation of China

Postdoctoral Research Funding Project of Jiangsu Province

Project of Science and Technology Bureau in Nantong City

Jiangsu Provincial Research Hospital

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12951-024-02827-4.pdf

Reference51 articles.

1. Liang Y, Li J, Xu H, Pang M, Hu C, Weng X, Xie W. Cepharanthine suppresses proliferation and metastasis and enhances apoptosis by regulating JAK2/Stat3 pathway in hepatocellular carcinoma. Cell Mol Biol. 2023;69(14):94–100. https://doi.org/10.14715/cmb/2023.69.14.15.

2. Sadagopan N, He AR. Recent progress in systemic therapy for advanced hepatocellular carcinoma. Int J Mol Sci. 2024;25(2):1259. https://doi.org/10.3390/ijms25021259.

3. Martínez-Rodríguez S, Cámara-Artigas A, Gavira JA. First 3-D structural evidence of a native-like intertwined dimer in the acylphosphatase family. Biochem Biophys Res Commun. 2023;682:85–90. https://doi.org/10.1016/j.bbrc.2023.09.053.

4. Wang S, Zhou L, Ji N, Sun C, Sun L, Sun J, Du Y, Zhang N, Li Y, Liu W, Lu W. Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression. Drug Resist Updat. 2023;69: 100976. https://doi.org/10.1016/j.drup.2023.100976.

5. Sakano Y, Noda T, Kobayashi S, Kitagawa A, Iwagami Y, Yamada D, et al. Clinical significance of acylphosphatase 1 expression in combined HCC-iCCA, HCC, and iCCA. Dig Dis Sci. 2022;67(8):3817–30. https://doi.org/10.1007/s10620-021-07266-x.